ASCENDIS PHARMA OPHTHALMOLOGY DIVISION AS has a total of 12 patent applications. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), Hong Kong and Singapore. Its main competitors in its focus markets pharmaceuticals and biotechnology are EVANS-FREKE STEPHEN, DEFENSIN THERAPEUTICS APS and GUBRA APS.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 2 | |
#2 | Hong Kong | 2 | |
#3 | Singapore | 2 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Israel | 1 | |
#7 | Mexico | 1 | |
#8 | New Zealand | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Weisbrod Samuel | 11 |
#2 | Voigt Tobias | 11 |
#3 | Rau Harald | 11 |
#4 | Knappe Thomas | 11 |
#5 | Laufer Burkhardt | 11 |
#6 | Reimann Romy | 7 |
#7 | Stark Sebastian | 7 |
#8 | Bisek Nicola | 7 |
#9 | Sprogøe Kennett | 6 |
#10 | Sproge Kennett | 2 |
Publication | Filing date | Title |
---|---|---|
CN104755103A | VEGF neutralizing prodrugs for the treatment of ocular conditions | |
NZ623439A | Prevention and treatment of ocular conditions |